Palo Alto early-stage firm investing in AI, cloud/SaaS, fintech, security and healthcare; reported ~$20B AUM on Wikipedia's 2026 table, with a Dealroom analysis of SEC Form ADV filings implying ~$46.8B across US and UK entities. Notable exits include Slack and Qualtrics.
Flagship Pioneering
Venture Capital Firms
Cambridge, MA firm that founds and builds biotech and life-science companies; raised ~$5.29B between 2019 and 2023.
- Capabilities
- Biotech, Life sciences, Company creation
- Listing status
- Unclaimed
Is this your firm?
Claim this listing to keep your firm's details accurate and unlock featured placement.
Claim this listing — freeStartupBase verdict
Our score: 5.0/10
Cambridge, MA firm that founds and builds biotech and life-science companies; raised ~$5.29B between 2019 and 2023. Details are single-sourced for now — treat figures as indicative until corroborated.
Sources: en.wikipedia.org
Editorial review by StartupBase. Featured placements never affect our verdicts.
Pros & cons
Pros
- Covers Biotech, Life sciences, Company creation.
- Based in Cambridge.
Cons
- Single-source data — figures should be re-checked before acting on them.
- No verified official website on file yet.
Reviews
No user reviews yet — leave your email and we'll notify you when reviews open for Flagship Pioneering.
Related venture capital firms tools
Menlo Park venture firm (a16z) investing across AI, crypto, fintech and consumer; reported ~$90B+ AUM in 2026, with Form ADV filings implying over $100B. Notable exits include GitHub, Instagram and Wiz.
Chicago firm focused on deep tech and life sciences company creation; raised ~$6.38B between 2019 and 2023.